Stemedica Cell Technologies
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
6350 Nancy Ridge Dr Ste 106, San Diego, ...Phone Number
(858) 658-0910Website
www.stemedica.comRevenue
$23.4 MillionIndustry
About Stemedica Cell Technologies
Stemedica Cell Technologies, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing progenitor cell and protein therapeutics for underserved medical conditions. The company utilizes a proprietary platform technology to produce high-quality progenitor cell products in a cGMP licensed facility. Stemedica is actively advancing clinical trials in the United States for critical medical conditions, including ischemic stroke and Alzheimer's disease. With a team of experienced scientists and management, Stemedica aims to address significant healthcare challenges through innovative therapies.Explore more
Stemedica Cell Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Stemedica Cell Technologies
Compare insights from companies similar to Stemedica Cell Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Stemedica Cell Technologies Tech Stack
A closer look at the technologies used by Stemedica Cell Technologies
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Stemedica Cell Technologies
Sign Up For FreeTo access detailed company insights
Stemedica Cell Technologies, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing progenitor cell and protein therapeutics for underserved medical conditions. The company utilizes a proprietary platform technology to produce high-quality progenitor cell products in a cGMP licensed facility. Stemedica is act... Read More
